These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence. Bacchetta F; Mathias A; Schluep M; Du Pasquier R Mult Scler; 2017 Feb; 23(2):300-303. PubMed ID: 28165319 [TBL] [Abstract][Full Text] [Related]
23. Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics. Verheyen J; Maizus K; Feist E; Tolman Z; Knops E; Saech J; Spengler L; Waterboer T; Burmester GR; Pawlita M; Pfister H; Rubbert-Roth A Med Microbiol Immunol; 2015 Oct; 204(5):613-8. PubMed ID: 25678083 [TBL] [Abstract][Full Text] [Related]
24. High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients. Schneider-Hohendorf T; Schulte-Mecklenbeck A; Ostkamp P; Janoschka C; Pawlitzki M; Luessi F; Zipp F; Meuth SG; Klotz L; Wiendl H; Gross CC; Schwab N Mult Scler; 2021 Sep; 27(10):1491-1496. PubMed ID: 33150829 [TBL] [Abstract][Full Text] [Related]
25. Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters. Schwab N; Schneider-Hohendorf T; Hoyt T; Gross CC; Meuth SG; Klotz L; Foley JF; Wiendl H Mult Scler; 2018 Apr; 24(5):563-573. PubMed ID: 28847222 [TBL] [Abstract][Full Text] [Related]
32. Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort. Dominguez-Mozo MI; Rus M; Santiago JL; Izquierdo G; Casanova I; Galan V; Garcia-Martinez MA; Arias-Leal AM; García-Montojo M; Pérez-Pérez S; Arroyo R; Alvarez-Lafuente R Eur J Clin Invest; 2017 Feb; 47(2):158-166. PubMed ID: 28036121 [TBL] [Abstract][Full Text] [Related]
33. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy. Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911 [TBL] [Abstract][Full Text] [Related]
34. Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study. Bellizzi A; Anzivino E; Rodio DM; Cioccolo S; Scrivo R; Morreale M; Pontecorvo S; Ferrari F; Di Nardo G; Nencioni L; Carluccio S; Valesini G; Francia A; Cucchiara S; Palamara AT; Pietropaolo V Virol J; 2013 Sep; 10():298. PubMed ID: 24079660 [TBL] [Abstract][Full Text] [Related]
36. JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus. Zingaropoli MA; Iannetta M; Pontecorvo S; Anzivino E; Prezioso C; Rodio DM; Morreale M; D'Abramo A; Oliva A; Lichtner M; Cortese A; Frontoni M; Pietropaolo V; Francia A; Mastroianni CM; Vullo V; Ciardi MR Biomed Res Int; 2018; 2018():5297980. PubMed ID: 29682547 [TBL] [Abstract][Full Text] [Related]
37. Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab. Mancuso R; Agostini S; Hernis A; Caputo D; Galimberti D; Scarpini E; Clerici M Front Neurol; 2022; 13():819911. PubMed ID: 35359635 [TBL] [Abstract][Full Text] [Related]
38. Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study. Jilek S; Jaquiéry E; Hirsch HH; Lysandropoulos A; Canales M; Guignard L; Schluep M; Pantaleo G; Du Pasquier RA Lancet Neurol; 2010 Mar; 9(3):264-72. PubMed ID: 20117055 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA miR-J1-5p as a potential biomarker for JC virus infection in the gastrointestinal tract. Link A; Balaguer F; Nagasaka T; Boland CR; Goel A PLoS One; 2014; 9(6):e100036. PubMed ID: 24932487 [TBL] [Abstract][Full Text] [Related]